LONDON, June 10, 2017 /PRNewswire/ --
Study shows patients treated with TheraSphere® maintain quality of life throughout 90 day post-treatment period
BTG plc (LSE: BTG), a global specialist healthcare company, today announced the results of a pilot study evaluating the...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]ith-therasphere-627631553.html